Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes.

Niiya M, Endo M, Shang D, Zoltick PW, Muvarak NE, Cao W, Jin SY, Skipwith CG, Motto DG, Flake AW, Zheng XL.

Mol Ther. 2009 Jan;17(1):34-41. doi: 10.1038/mt.2008.223. Epub 2008 Oct 28.

2.

Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy.

Laje P, Shang D, Cao W, Niiya M, Endo M, Radu A, DeRogatis N, Scheiflinger F, Zoltick PW, Flake AW, Zheng XL.

Blood. 2009 Mar 5;113(10):2172-80. doi: 10.1182/blood-2008-08-173021. Epub 2009 Jan 13.

3.

Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models.

Pickens B, Mao Y, Li D, Siegel DL, Poncz M, Cines DB, Zheng XL.

Blood. 2015 May 21;125(21):3326-34. doi: 10.1182/blood-2014-07-587139. Epub 2015 Mar 23.

PMID:
25800050
4.

ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Zheng XL.

Annu Rev Med. 2015;66:211-25. doi: 10.1146/annurev-med-061813-013241. Review.

5.

AAV-mediated expression of an ADAMTS13 variant prevents shigatoxin-induced thrombotic thrombocytopenic purpura.

Jin SY, Xiao J, Bao J, Zhou S, Wright JF, Zheng XL.

Blood. 2013 May 9;121(19):3825-9, S1-3. doi: 10.1182/blood-2013-02-486779. Epub 2013 Mar 20.

6.

Molecular biology of ADAMTS13 and diagnostic utility of ADAMTS13 proteolytic activity and inhibitor assays.

Shelat SG, Ai J, Zheng XL.

Semin Thromb Hemost. 2005 Dec;31(6):659-72. Review.

7.

The novel ADAMTS13-p.D187H mutation impairs ADAMTS13 activity and secretion and contributes to thrombotic thrombocytopenic purpura in mice.

De Cock E, Hermans C, De Raeymaecker J, De Ceunynck K, De Maeyer B, Vandeputte N, Vandenbulcke A, Deckmyn H, Rottensteiner H, De Maeyer M, De Meyer SF, Vanhoorelbeke K.

J Thromb Haemost. 2015 Feb;13(2):283-92. doi: 10.1111/jth.12804. Epub 2015 Jan 17.

PMID:
25442981
8.

Adenoviral-mediated gene transfer restores plasma ADAMTS13 antigen and activity in ADAMTS13 knockout mice.

Trionfini P, Tomasoni S, Galbusera M, Motto D, Longaretti L, Corna D, Remuzzi G, Benigni A.

Gene Ther. 2009 Nov;16(11):1373-9. doi: 10.1038/gt.2009.98. Epub 2009 Aug 13.

PMID:
19675594
9.

Molecular cloning, in vitro expression and functional characterization of canine ADAMTS13.

Maruyama H, Ito K, Okabayashi K, Sakai M, Kano R, Watari T, Hasegawa A, Kamata H.

Res Vet Sci. 2012 Aug;93(1):213-8. doi: 10.1016/j.rvsc.2011.06.006. Epub 2011 Jul 2.

PMID:
21724217
11.

Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children.

Loirat C, Girma JP, Desconclois C, Coppo P, Veyradier A.

Pediatr Nephrol. 2009 Jan;24(1):19-29. doi: 10.1007/s00467-008-0863-5. Epub 2008 Jun 24. Review.

PMID:
18574602
12.

[ADAMTS13, von Willebrand factor specific cleaving protease].

Veyradier A, Coppo P.

Med Sci (Paris). 2011 Dec;27(12):1097-105. doi: 10.1051/medsci/20112712016. Epub 2011 Dec 23. Review. French.

13.

Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.

Jian C, Xiao J, Gong L, Skipwith CG, Jin SY, Kwaan HC, Zheng XL.

Blood. 2012 Apr 19;119(16):3836-43. doi: 10.1182/blood-2011-12-399501. Epub 2012 Jan 30.

14.

Conformational activation of ADAMTS13.

South K, Luken BM, Crawley JT, Phillips R, Thomas M, Collins RF, Deforche L, Vanhoorelbeke K, Lane DA.

Proc Natl Acad Sci U S A. 2014 Dec 30;111(52):18578-83. doi: 10.1073/pnas.1411979112. Epub 2014 Dec 15.

15.

Thrombotic thrombocytopenic purpura associated with von Willebrand factor-cleaving protease (ADAMTS13) deficiency in children.

Loirat C, Veyradier A, Girma JP, Ribba AS, Meyer D.

Semin Thromb Hemost. 2006 Mar;32(2):90-7. Review.

PMID:
16575683
16.

[Genetic polymorphism of von Willebrand factor (VWF)-cleaving protease, ADAMTS13].

Kokame K.

Brain Nerve. 2008 Nov;60(11):1325-32. Review. Japanese.

PMID:
19069166
17.

Current concepts in thrombotic thrombocytopenic purpura.

Tsai HM.

Annu Rev Med. 2006;57:419-36. Review.

18.

ADAMTS13 and microvascular thrombosis.

Tsai HM.

Expert Rev Cardiovasc Ther. 2006 Nov;4(6):813-25. Review.

19.

Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.

Manea M, Karpman D.

Pediatr Nephrol. 2009 Mar;24(3):447-58. doi: 10.1007/s00467-008-0986-8. Epub 2008 Sep 20. Review.

PMID:
18807073
20.

Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort.

Bentley MJ, Wilson AR, Rodgers GM.

Vox Sang. 2013 Nov;105(4):313-8. doi: 10.1111/vox.12050. Epub 2013 May 11.

PMID:
23662653
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk